Based on Wang Jiyue (王骥跃), 梦想与浮沉 (Dreams and Drift: The Inside Story of China's A-Share IPO Market, 2004-2014)
Dreams and Drift is an insider account of China's A-share IPO market from 2004 to 2014, written by an investment banking professional who witnessed the system's evolution firsthand. The book exposes the mechanics, contradictions, and lessons of China's unique IPO regime — a system where government approval (not market forces) determines which companies go public, when they list, and at what price.
Core thesis: China's IPO market is a microcosm of the tension between market reform and government control. Understanding this tension is essential for any investor navigating Chinese capital markets.
The book is not a trading manual but a structural guide. For investors, it provides:
Key period covered: 2004-2014, encompassing the 2005-2007 mega-bull market, the 2008 crash, the 2009-2010 ChiNext launch, multiple IPO suspensions and resumptions, and the early stages of registration-based reform.
Unlike the registration-based systems in the US and Hong Kong, China's IPO system during 2004-2014 was approval-based:
| Feature | China (Approval) | US (Registration) |
|---|---|---|
| Gatekeeper | CSRC (China Securities Regulatory Commission) | SEC (disclosure-based) |
| Decision criterion | Substantive merit judgment (profitability, industry policy) | Disclosure adequacy |
| Approval timeline | 1-3 years (often longer) | 3-6 months |
| Pricing | Government-guided caps (at times) | Market-determined |
| Supply control | CSRC controls pace and number of IPOs | Market-driven |
| Implicit guarantee | "Approved = government endorsement" perception | No such perception |
Company applies to CSRC
↓
Pre-review by CSRC staff (材料受理)
↓
Feedback and revision rounds (反馈意见) — typically 2-5 rounds
↓
CSRC Issuance Review Committee (发审委) review meeting
↓
Approved or Rejected
↓
If approved: Waiting for "window" to issue (发行窗口)
↓
Roadshow and pricing
↓
Listing on exchange (上市)
Critical insight: The pipeline creates an artificial scarcity of new listings. At various points, 600-800 companies were queued for approval, waiting years. This scarcity inflated IPO first-day returns and created perverse incentives.
| Player | Role | Incentives |
|---|---|---|
| CSRC | Regulator and gatekeeper | Market stability, political mandate, reform vs. control |
| Sponsor/Underwriter (保荐人) | Prepares IPO application, due diligence | Fees (2-5% of raise); reputation; throughput |
| Issuing company | Seeks to raise capital and list | Maximum valuation; access to public markets |
| Institutional investors | Price discovery in book-building | Allocation, flip-profit, long-term investment |
| Retail investors | Apply for IPO shares in lottery | "Free money" perception from first-day pops |
| Local government | Supports local company listings | GDP, tax revenue, political achievement |
| Year | Event | Impact |
|---|---|---|
| 2004 | Sponsor system (保荐制) introduced | Sponsors personally liable for IPO quality; improved due diligence |
| 2005 | Split-share reform (股权分置改革) | Non-tradable shares become tradable; fundamental market structure change |
| 2006-2007 | IPO resumption after 1-year suspension | Flood of pent-up supply meets bull market euphoria |
| 2008 | Global financial crisis | IPOs suspended September 2008 |
| 2009 | IPOs resume; ChiNext (创业板) launches | New board for growth companies; pricing reform attempted |
| 2009-2010 | Market-based IPO pricing experiment | PE ratios soar to 50-100x; "three highs" problem (高发行价、高市盈率、高超募) |
| 2012 | IPO suspended again (Nov 2012 - Jan 2014) | Longest suspension; 800+ companies in queue |
| 2013 | CSRC announces reform direction toward registration system | Market-oriented pricing, enhanced disclosure, sponsor accountability |
| 2014 | IPO resumes with new rules | Pricing caps reinstated (23x PE); gradual reform continues |
The book identifies a repeating pattern unique to China:
Bull market → IPO approvals accelerate → Market overheats
↓
Market crash → Public anger at "IPO sucking blood from market"
↓
CSRC suspends IPOs to "protect investors"
↓
Suspension creates even larger pipeline backlog
↓
Market stabilizes → Pressure to resume IPOs (companies need capital)
↓
IPO resumes → Initial euphoria → cycle repeats
Investment implication: IPO suspensions and resumptions are major market signals. Suspension often coincides with market bottoms (fear is maximum); resumption signals regulatory confidence.
| Period | Pricing Method | Outcome |
|---|---|---|
| Pre-2005 | Fixed PE cap (~20x) | Guaranteed first-day pop; "lottery economics" |
| 2005-2008 | Book-building with window guidance | Some market influence; still constrained |
| 2009-2012 | Market-based pricing experiment | PE ratios exploded (60-100x); institutional gaming; retail losses |
| 2014 onwards | 23x PE cap reinstated | Return to guaranteed first-day pop; artificial pricing |
The Issuance Review Committee (发审委) evaluates IPO applications based on:
Financial thresholds (hard requirements):
Substantive judgment (soft factors):
Red flags that cause rejection:
| Red Flag | Why It Matters |
|---|---|
| Revenue concentration > 50% from single customer | Sustainability concern |
| Frequent related-party transactions | Tunneling risk |
| Significant self-dealing by controlling shareholder | Governance failure |
| Inconsistent tax treatment | Potential fraud indicator |
| Material pending litigation | Uncertain liability |
| Recent changes to accounting policies | Earnings manipulation suspicion |
| Inconsistency between reported profit and cash flow | Earnings quality doubt |
The 2004 sponsor system (保荐制) made individual sponsors personally accountable:
Investment insight for evaluating newly listed companies:
When market-based pricing was allowed (2009-2012):
Step 1: Issuer and underwriter propose preliminary price range
Step 2: Institutional roadshow (1-2 weeks)
Step 3: Institutional investors submit price bids
Step 4: Underwriter determines final price based on bids
Step 5: Allocation to institutional investors
Step 6: Retail investors apply at the determined price
Step 7: Listing day
Problem identified in the book: Institutional investors had incentive to bid high (overstate their valuation) to secure allocation, then flip on listing day. This created a "winner's curse" where the IPO price was systematically too high relative to fundamental value.
During 2009-2012, market-based pricing produced:
| Metric | Healthy Range | Actual (2010-2011) |
|---|---|---|
| IPO PE ratio | 15-25x | 50-100x |
| Over-subscription ratio | 10-50x | 100-500x |
| Funds raised vs. planned | 100-120% | 150-300% (超募) |
| First-day return | 10-30% | -20% to +50% (high variance) |
The excess capital raised (超募资金) was often wasted on unnecessary projects or sat idle in bank accounts — a massive misallocation of capital.
After the market-based experiment failed, CSRC reimposed a de facto 23x PE cap:
Investment implication: Under the 23x cap, IPO subscription is a near-guaranteed short-term profit — but the opportunity cost (locked capital during application period) and allocation probability must be calculated.
For retail investors in the 23x PE cap era:
Expected value calculation:
Average first-day pop: 44%
Average consecutive limit-ups: 7-10 days
Average total gain from IPO price to open trading: 150-300%
Win rate in lottery: 0.01% - 0.05% (per application)
Capital locked: 2-3 days per application
Strategy: Apply for every available IPO with maximum eligible shares
- No analysis needed (guaranteed mispricing)
- Return driven by lottery probability × expected pop
- Requires maintaining stock portfolio for eligibility (市值配售)
For investors considering buying after the initial pop settles:
Wait period: Do not buy any newly listed stock until:
Evaluation framework:
| Factor | What to Check |
|---|---|
| Prospectus quality | Thoroughness of risk disclosure; clarity of business description |
| Use of proceeds | Are planned investments sensible? Timeline realistic? |
| Pre-IPO shareholders | PE/VC investors present? Their entry price vs. current price? |
| Lock-up schedule | When do pre-IPO shares become tradable? Major selling pressure dates? |
| Comparable valuation | PE premium vs. listed peers — how much "new listing premium" is priced in? |
| Insider behavior | Are key shareholders reducing at first opportunity? |
| Post-listing earnings | Does the first earnings report show "face-changing" (变脸) — decline after listing? |
Lock-up periods for pre-IPO shareholders:
Controlling shareholder: 36 months
Other pre-IPO shareholders: 12 months
PE/VC investors: 12 months (sometimes 36)
Strategic investors: 12-18 months
Investment implications:
1. Mark all unlock dates on calendar when analyzing a new listing
2. Expect selling pressure in the 1-2 weeks before unlock dates
3. If stock drops significantly on unlock selling, it may create buying opportunity
(if fundamentals are intact)
4. If controlling shareholder reduces at first opportunity → major red flag
| Signal | Interpretation | Action |
|---|---|---|
| IPO suspension announced | Market in crisis; CSRC protecting stability | Contrarian buy signal (market near bottom) |
| IPO resumes after long suspension | CSRC confident market can absorb supply | Cautiously bullish |
| IPO pace accelerates sharply | Government draining excess liquidity | Warning: market may be peaking |
| IPO pricing exceeds 30x PE systematically | Euphoria; regulatory arbitrage | Market is overheated |
| IPO rejection rate rises sharply | CSRC tightening quality standards | Positive for market quality long-term |
| Risk | Description | Mitigation |
|---|---|---|
| "Face-changing" earnings (业绩变脸) | Company's earnings decline shortly after listing | Wait for 2 post-listing quarterly reports before buying |
| Information asymmetry | Prospectus is written to sell; true problems hidden | Read the risk factors section carefully — it is the most honest part |
| Valuation anchoring | IPO price creates false anchor; market may overshoot | Use peer comparison and DCF, not IPO price as reference |
| Lock-up selling pressure | 60-70% of shares locked up at IPO; massive supply incoming | Map all unlock dates; reduce exposure before major unlocks |
| Shell value distortion | Small IPOs trade at premiums due to potential backdoor listing value | Do not pay for shell value; it is regulatory arbitrage, not fundamental value |
| Sponsor abandonment | After sponsor period ends (2-3 years), scrutiny decreases | Focus on companies with genuine institutional investor coverage |
□ Read full prospectus (not just summary)
□ Check pre-IPO earnings trajectory (3 years)
□ Compare prospectus financial projections to actual results
□ Identify all related-party transactions
□ Review top 10 shareholders and their backgrounds
□ Check if PE/VC investors are selling at first unlock
□ Compare valuation to nearest listed peers
□ Assess use of proceeds plan — is it realistic?
□ Read the "Risk Factors" section word by word
□ Check media reports for controversy or fraud allegations
□ Review the sponsor's track record (sanctions, failures)
□ Calculate the fully diluted market cap (after all shares unlock)
| Scenario | Maximum Position |
|---|---|
| IPO subscription (lottery) | Apply with full eligible amount (risk is negligible) |
| Buying on first day of open trading | 2% of portfolio maximum |
| Buying after 20-day settling period | 3-5% if fundamentals check out |
| Buying after first annual report post-listing | Up to 8% if thesis is strong |
| Buying unlock dip (fundamentals intact) | Up to 5% |
The book identifies several behavioral traps created by China's IPO system:
"Free money" illusion:
"Government guarantee" fallacy:
"New listing premium" trap:
Pre-listing: Excitement → "This company sounds revolutionary!"
First day: Euphoria → consecutive limit-up boards, unrealized gains soar
First month: Overconfidence → "I should have bought more"
Month 2-3: Anchoring → "It was ¥80 last month, ¥60 is a bargain"
Month 6: Denial → "The fundamentals haven't changed" (but they have)
Month 12: Lock-up selling → Price drops 30%; capitulation begins
Year 2: Acceptance → Sell at a loss or hold indefinitely as "long-term investment"
| Mistake | Description | Lesson |
|---|---|---|
| Buying at the peak of limit-up streak | Chasing momentum on day 7-10 of consecutive limit-ups | The music stops eventually; late buyers bear the losses |
| Ignoring prospectus risk factors | Only reading the "strengths" and "business description" sections | Risk factors written by lawyers are the most informative section |
| Anchoring to IPO price for valuation | "It IPO'd at ¥20, now it's ¥15 — must be a bargain" | IPO price is artificial; use fundamental valuation |
| Treating all IPOs as equal | "If IPO subscription is profitable, all new stocks are good" | Subscription and secondary market trading are completely different |
| Ignoring lock-up dynamics | Not knowing when 60-70% of shares become tradable | Major selling pressure can crater stocks regardless of fundamentals |
| Confusing liquidity with quality | "This stock trades 500M RMB/day — it must be good" | High volume in newly listed stocks is often speculation, not conviction |
| Assuming past IPO returns predict future | "IPOs have returned 200% on average, so this one will too" | Average masks massive dispersion; some IPOs lose 50%+ |
| Not reading the use-of-proceeds | Company raises 3x planned amount but has no good use for it | Excess capital often destroyed through bad investments |
| Following sponsor recommendation blindly | "The underwriter says fair value is ¥50" | Underwriter's job is to sell at the highest price; they are not independent analysts |
| Holding losers hoping for "return to IPO price" | Price may never return to the inflated post-listing peak | The market was wrong to push it that high in the first place |
Company: Leading provider of industrial automation equipment
IPO price: ¥23.50 (22.98x trailing PE — standard under 23x cap)
Industry PE: 35-45x for listed peers
Expected first-day pop: Very likely
Action: Apply for IPO subscription through brokerage lottery
Allocation: Won 500 shares (typical small retail allocation)
Cost basis: ¥23.50 × 500 = ¥11,750
Day 1: Limit up to ¥25.85 (+10%)
Day 2: Limit up to ¥28.44 (+10%)
Day 3: Limit up to ¥31.28 (+10%)
Day 4: Limit up to ¥34.41 (+10%)
Day 5: Limit up to ¥37.85 (+10%)
Day 6: Board opens — high ¥42.50, close ¥39.80
Decision point: SELL IPO allocation on first open day
Sold: 500 shares at ¥40.00
Profit: (¥40.00 - ¥23.50) × 500 = ¥8,250 (70% return)
Rule: Always sell IPO allocation within 2 days of board opening.
Do not hold hoping for further gains — this is lottery profit, lock it in.
Weeks 1-4 after open: Stock oscillates between ¥35-¥48
Volume: Very high (speculative trading)
Analysis: No quarterly earnings yet; prospectus data is stale
Action: DO NOTHING. Add to watchlist only.
Continue monitoring but no position.
First quarterly report post-listing released:
Revenue: +25% YoY ✓
Net profit: +30% YoY ✓
Operating cash flow: positive and growing ✓
Gross margin: 42% (in line with prospectus) ✓
Peer comparison:
Company PE: 35x at current price ¥38
Peer average PE: 40x
Company growth rate: Higher than peer average
Assessment: Slightly undervalued relative to peers
Use of proceeds check:
¥500M raised for new production line — on schedule
¥200M for R&D center — groundbreaking completed
¥100M excess funds (超募) — deposited in bank (no misuse yet)
Stock pulls back to ¥34 on broad market weakness
PE: 30x (below peer average)
Growth: Still strong per channel checks
Lock-up calendar:
12-month unlock (PE/VC + small shareholders): 10 months away
36-month unlock (controlling shareholder): 32 months away
Decision: INITIATE position
Buy: 1,000 shares at ¥34.00 (4% of portfolio)
Stop-loss: Will sell if Q2 earnings show deceleration > 50% YoY
Review trigger: 12-month lock-up expiry (reduce exposure before)
Month 6: Q2 earnings — revenue +28%, profit +32%. Thesis intact.
Action: HOLD
Month 9: Stock at ¥45. PE = 38x. Pre-lock-up selling period approaching.
Action: TRIM 30% at ¥45 (sell 300 shares, keep 700)
Reason: Lock-up selling pressure likely in 1-3 months
Month 12: Lock-up expires. Stock drops from ¥42 to ¥35 on PE/VC selling.
Check: PE/VC sold 60% of holdings (typical exit behavior)
Fundamentals: Q3 earnings still strong (+26% YoY)
Action: RE-ADD at ¥35 (buy 300 shares back). Total: 1,000 shares
Month 18: Stock at ¥52. Full-year earnings confirm sustained growth.
Company now has 4 quarters of listed track record.
Upgraded conviction: Increase to 6% of portfolio (buy 500 more shares).
Year 2.5: Revenue growth decelerates to 12%. Industry competition intensifies.
New entrants with lower pricing. Margin compression begins.
PE still 35x but growth no longer justifies it.
Decision: EXIT entire position at ¥48.
Average cost: ~¥36
Return: ~33% over 2 years + dividends
Post-mortem: Good discipline. Waited for track record, managed lock-up
risk, exited when growth thesis weakened. Record lessons in journal.
"中国的IPO不是一个市场行为，而是一个行政行为披上了市场的外衣。" — China's IPO is not a market act but an administrative act dressed in market clothing.
"审批制最大的问题不是审不出好公司，而是让投资者误以为审批通过就意味着安全。" — The biggest problem with the approval system is not that it fails to identify good companies, but that it gives investors the false impression that approval means safety.
"每次暂停IPO，都是在用一个错误去纠正另一个错误。" — Every IPO suspension corrects one mistake with another mistake.
"超募资金是中国资本市场最大的浪费之一。" — Excess IPO capital raised is one of the greatest wastes in China's capital markets.
"注册制不是放任不管，而是把监管重心从事前审批转向事中事后监管。" — The registration system is not laissez-faire; it shifts regulatory focus from pre-approval to ongoing and post-hoc supervision.
"投资新股最危险的时候，恰恰是看起来最安全的时候——连续涨停板的尾声。" — The most dangerous time to invest in new listings is precisely when it looks safest — at the tail end of consecutive limit-up boards.
"一个健康的IPO市场应该让投资者感到适度的恐惧，而不是确定的贪婪。" — A healthy IPO market should make investors feel moderate fear, not certain greed.
"读招股说明书的风险因素部分，就像读一个人写的检讨书——这是他最诚实的时候。" — Reading the risk factors section of a prospectus is like reading someone's self-criticism letter — this is when they are most honest.
"改革的方向是对的，但改革的节奏必须与市场的承受能力匹配。" — The direction of reform is correct, but the pace must match the market's capacity to absorb change.
"梦想是IPO的起点，浮沉是市场的常态。能在浮沉中坚持梦想的企业，才值得投资。" — Dreams are the starting point of an IPO; drift is the norm of the market. Only companies that persist through the drift are worth investing in.